{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:15:37Z","timestamp":1789604137178,"version":"build-2803163510"},"reference-count":49,"publisher":"Scientific Scholar","content-domain":{"domain":["cytojournal.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma (MM). Cytopathologists involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC), who have an interest in the field contributed to this update. Reference material includes peer-reviewed publications and textbooks. This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists, who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in cape town. During the previous IMIG biennial meetings, thorough discussions have resulted in published guidelines for the pathologic diagnosis of MM. However, previous recommendations have stated that the diagnosis of MM should be based on histological material only.[12] Accumulating evidence now indicates that the cytological diagnosis of MM supported by ancillary techniques is as reliable as that based on histopathology, although the sensitivity with cytology may be somewhat lower.[345] Recognizing that noninvasive diagnostic modalities benefit both the patient and the health system, future recommendations should include cytology as an accepted method for the diagnosis of this malignancy.[67] The article describes the consensus of opinions of the authors on how cytology together with ancillary testing can be used to establish a reliable diagnosis of MM.<\/jats:p>","DOI":"10.4103\/1742-6413.170726","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T09:15:16Z","timestamp":1448874916000},"page":"26","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology"],"prefix":"10.25259","volume":"12","author":[{"given":"Anders","family":"Hjerpe","sequence":"first","affiliation":[{"name":"Address: Department of Laboratory Medicine, Division of Clinical Pathology\/Cytology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-14186 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ascoli","sequence":"additional","affiliation":[{"name":"Department of Radiological, Oncological and Pathological Sciences, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bedrossian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rush University Medical College, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Boon","sequence":"additional","affiliation":[{"name":"Leiden Cytology and Pathology Laboratory, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenette","family":"Creaney","sequence":"additional","affiliation":[{"name":"National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, QEII Medical Centre, WA 6009, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Dejmek","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Lund University, Malm\u00f6 University Hospital, SE-205 02 Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Dobra","sequence":"additional","affiliation":[{"name":"Address: Department of Laboratory Medicine, Division of Clinical Pathology\/Cytology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-14186 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrogio","family":"Fassina","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padova, 35121 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Field","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, St. Vincents Hospital, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Firat","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u0130stanbul University, \u0130stanbul Faculty of Medicine, Capa, Fatih 34093, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kamei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yamaguchi Grand Medical Center, Hofu City, Yamaguchi Pref, 747-8511, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Cancer Education and Research Center, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire W.","family":"Michael","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, University Hospitals Case Medical Center, MSPTH 5077, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgen","family":"\u00d6nder","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Hacettepe University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Segal","sequence":"additional","affiliation":[{"name":"Department of Tissue Pathology, Pathwest Laboratory Medicine WA, QE2 Medical Centre, Western Australia 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vielh","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Gustave Roussy Comprehensive Cancer Center, 94805 Vilejuif Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"key":"10.4103\/1742-6413.170726\/ref-1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.4103\/1742-6413.170726\/ref-2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.4103\/1742-6413.170726\/ref-3","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/dc.21303","article-title":"The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma","volume":"38","author":"Rakha","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncy.21342","article-title":"The diagnosis of malignant mesothelioma in effusion cytology: A reappraisal and results of a multi-institution survey","volume":"121","author":"Paintal","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAT.0b013e32835bc848","article-title":"A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: Results of a 20 year audit","volume":"45","author":"Segal","year":"2013","journal-title":"Pathology"},{"key":"10.4103\/1742-6413.170726\/ref-6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2303.2010.00840.x","article-title":"Should cytology be an acceptable means of diagnosing malignant mesothelioma?","volume":"22","author":"Sheaff","year":"2011","journal-title":"Cytopathology"},{"key":"10.4103\/1742-6413.170726\/ref-7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2303.2000.00247.x","article-title":"The cytology of malignant mesothelioma","volume":"11","author":"Whitaker","year":"2000","journal-title":"Cytopathology"},{"key":"10.4103\/1742-6413.170726\/ref-9","article-title":"Malignant Effusions: A Multomodal Approach to Cytologic Diagnosis","author":"Bedrossian","year":"1994"},{"key":"10.4103\/1742-6413.170726\/ref-10","article-title":"Cytopathology of malignant effusions","author":"Tao","year":"1996"},{"key":"10.4103\/1742-6413.170726\/ref-11","article-title":"Serous Effusions: Etiology, Diagnosis, Prognosis, and Therapy","author":"Davidson","year":"2012"},{"key":"10.4103\/1742-6413.170726\/ref-12","article-title":"The cytohistology of the serous membranes","author":"Michael","year":"2015"},{"key":"10.4103\/1742-6413.170726\/ref-13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/sonc.2002.30230","article-title":"Multimodality treatment of diffuse malignant pleural mesothelioma","volume":"29","author":"Zellos","year":"2002","journal-title":"Semin Oncol"},{"key":"10.4103\/1742-6413.170726\/ref-14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107327480601300402","article-title":"Malignant pleural mesothelioma: A comprehensive review","volume":"13","author":"Ismail-Khan","year":"2006","journal-title":"Cancer Control"},{"key":"10.4103\/1742-6413.170726\/ref-15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000369198","article-title":"The implementation of liquid-based cytology for lung and pleural-based diseases","volume":"58","author":"Michael","year":"2014","journal-title":"Acta Cytol"},{"key":"10.4103\/1742-6413.170726\/ref-16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/01913128809048481","article-title":"A rapid and simple method for electron microscopy of paraffin-embedded tissue","volume":"12","author":"Wid\u00e9hn","year":"1988","journal-title":"Ultrastruct Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-17","first-page":"401","article-title":"Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid","volume":"26","author":"Kwee","year":"1982","journal-title":"Acta Cytol"},{"key":"10.4103\/1742-6413.170726\/ref-18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cncy.21269","article-title":"Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology","volume":"21","author":"Matsumoto","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-0339(199902)20:2<57::AID-DC2>3.0.CO;2-M","article-title":"Cytologic diagnosis of malignant mesothelioma, with particular emphasis on the epithelial noncohesive cell type","volume":"20","author":"Kho-Duffin","year":"1999","journal-title":"Diagn Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-20","first-page":"221","article-title":"Analysis of number, size and distribution patterns of lipid vacuoles in benign and malignant mesothelial cells","volume":"6","author":"Boon","year":"1984","journal-title":"Anal Quant Cytol"},{"key":"10.4103\/1742-6413.170726\/ref-21","first-page":"443","article-title":"Qualitative distinctive differences between the vacuoles of mesothelioma cells and of cells from metastatic carcinoma exfoliated in pleural fluid","volume":"28","author":"Boon","year":"1984","journal-title":"Acta Cytol"},{"key":"10.4103\/1742-6413.170726\/ref-22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/dc.2840060104","article-title":"\u201cThick\u201d cell membranes revealed by immunocytochemical staining: A clue to the diagnosis of mesothelioma","volume":"6","author":"Leong","year":"1990","journal-title":"Diagn Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.humpath.2014.03.006","article-title":"Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: A comparative study","volume":"45","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Hum Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/1097-0142(19940115)73:2<464::AID-CNCR2820730235>3.0.CO;2-#","article-title":"Carcinoembryonic antigen-like reactivity in malignant mesothelioma. A comparison between different commercially available antibodies","volume":"73","author":"Dejmek","year":"1994","journal-title":"Cancer"},{"key":"10.4103\/1742-6413.170726\/ref-25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2303.2000.00211.x","article-title":"Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: Stepwise logistic regression analysis","volume":"11","author":"Dejmek","year":"2000","journal-title":"Cytopathology"},{"key":"10.4103\/1742-6413.170726\/ref-26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/dc.20208","article-title":"The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: A comparative study","volume":"32","author":"Saad","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-27","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/modpathol.2010.134","article-title":"Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium","volume":"23","author":"Sato","year":"2010","journal-title":"Mod Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lungcan.2013.12.009","article-title":"How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study","volume":"83","author":"Husain","year":"2014","journal-title":"Lung Cancer"},{"key":"10.4103\/1742-6413.170726\/ref-29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/AJCP5KNL7QTELLYI","article-title":"Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells","volume":"141","author":"Minato","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncy.20071","article-title":"The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions","volume":"118","author":"Hasteh","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-31","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/pin.12053","article-title":"Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: A case report","volume":"63","author":"Washimi","year":"2013","journal-title":"Pathol Int"},{"key":"10.4103\/1742-6413.170726\/ref-33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2303.2010.00829.x","article-title":"The diagnostic and molecular characteristics of malignant mesothelioma and ovarian\/peritoneal serous carcinoma","volume":"22","author":"Davidson","year":"2011","journal-title":"Cytopathology"},{"key":"10.4103\/1742-6413.170726\/ref-34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1309\/2H0NVRERPP2LJDUA","article-title":"Malignant peritoneal mesothelioma in women: A study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis","volume":"123","author":"Baker","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.4103\/1742-6413.170726\/ref-36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thx.2006.068114","article-title":"Soluble mesothelin in effusions: A useful tool for the diagnosis of malignant mesothelioma","volume":"62","author":"Creaney","year":"2007","journal-title":"Thorax"},{"key":"10.4103\/1742-6413.170726\/ref-37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.athoracsur.2007.07.042","article-title":"Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions","volume":"85","author":"Pass","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.4103\/1742-6413.170726\/ref-38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.lungcan.2013.09.016","article-title":"Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma","volume":"82","author":"Creaney","year":"2013","journal-title":"Lung Cancer"},{"key":"10.4103\/1742-6413.170726\/ref-39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.resinv.2013.02.002","article-title":"Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma","volume":"51","author":"Fujimoto","year":"2013","journal-title":"Respir Investig"},{"key":"10.4103\/1742-6413.170726\/ref-40","doi-asserted-by":"crossref","first-page":"e72030","DOI":"10.1371\/journal.pone.0072030","article-title":"Hyaluronan and N-ERC\/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma","volume":"8","author":"Mundt","year":"2013","journal-title":"PLoS One"},{"key":"10.4103\/1742-6413.170726\/ref-41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Benjamin","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.4103\/1742-6413.170726\/ref-42","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbagen.2012.02.005","article-title":"Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies?","volume":"1820","author":"Bovin","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.4103\/1742-6413.170726\/ref-43","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"N Engl J Med"},{"key":"10.4103\/1742-6413.170726\/ref-44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/clinchem\/40.5.777","article-title":"Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content","volume":"40","author":"Nurminen","year":"1994","journal-title":"Clin Chem"},{"key":"10.4103\/1742-6413.170726\/ref-45","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.7314\/APJCP.2012.13.9.4745","article-title":"Diagnostic value of fluorescence in situ hybridization assay in malignant mesothelioma: A meta-analysis","volume":"13","author":"Wan","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"10.4103\/1742-6413.170726\/ref-46","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/dc.23165","article-title":"Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis","volume":"42","author":"Adell","year":"2014","journal-title":"Diagn Cytopathol"},{"key":"10.4103\/1742-6413.170726\/ref-47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/modpathol.3800278","article-title":"Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: Malignant cells, proliferative mesothelial cells, and lymphocytes","volume":"18","author":"Zendehrokh","year":"2005","journal-title":"Mod Pathol"},{"key":"10.4103\/1742-6413.170726\/ref-48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2009.05.004","article-title":"Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions","volume":"68","author":"Flores-Staino","year":"2010","journal-title":"Lung Cancer"},{"key":"10.4103\/1742-6413.170726\/ref-49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/JTO.0b013e31823e0667","article-title":"Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma","volume":"7","author":"Pinelli","year":"2012","journal-title":"J Thorac Oncol"}],"container-title":["CytoJournal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cytojournal.com\/guidelines-for-cytopathologic-diagnosis-of-epithelioid-and-mixed-type-malignant-mesothelioma-complementary-statement-from-the-international-mesothelioma-interest-group-also-endorsed-by-the-internati\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cytojournal.com\/guidelines-for-cytopathologic-diagnosis-of-epithelioid-and-mixed-type-malignant-mesothelioma-complementary-statement-from-the-international-mesothelioma-interest-group-also-endorsed-by-the-internati\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T18:19:45Z","timestamp":1653675585000},"score":1,"resource":{"primary":{"URL":"https:\/\/cytojournal.com\/guidelines-for-cytopathologic-diagnosis-of-epithelioid-and-mixed-type-malignant-mesothelioma-complementary-statement-from-the-international-mesothelioma-interest-group-also-endorsed-by-the-internati\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":49,"alternative-id":["10.4103\/1742-6413.170726"],"URL":"https:\/\/doi.org\/10.4103\/1742-6413.170726","relation":{},"ISSN":["0974-5963"],"issn-type":[{"value":"0974-5963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]},"article-number":"26"}}